Product Overview
Prism Connect extracts clinical trial information directly from a site’s electronic health records (EHR).
Key benefits
- Cost savings: By eliminating the need to enter the same data in multiple systems, Prism Connect increases efficiency and saves cost.
- Process efficiencies: The sponsor receives the data faster, leading to accelerated delivery of novel therapies to patients.
- Cleaner data: The data is cleaner as many of the data points are migrated directly from the source (EHR).
Deployment
- Web based
- Cloud Hosted
Pricing
- Subscription
- License Fee
More Information
Reduces source data verification
Data migrated from the EHR in a validated solution does not need to be source data verified (the most expensive component of a clinical trial). Dramatically reducing the number of visits and allowing site monitors to focus on study conduct, not just data collection.
Provides certified copy source
When data is transmitted from the EHR to the clinical database, a copy of the migrated data included in the patient’s Continuity of Care Document (CCD) is stored in the source document-viewing feature called the Archiver. This is considered by the FDA to represent a certified copy of the source document. The Archiver allows the end user to view this copy of the source data remotely while comparing it to the data captured in the EDC system.
Eliminates double data entry
The duplication of data entry is reduced in the EHR and the EDC system. In a survey of investigative sites, coordinators reported that 80% to 100% of the required study data are already recorded in the EHR system. Since the data migration is cleaner, the site coordinator spends less time responding to data queries that result from transcription errors.
About the company
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life.
We are a global provider of consulting, and outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas. ICON has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.
ICON’s technology solutions are focused on the factors most critical to our customers. With expertise in technology harmonisation and systems integration, our innovative tools and platforms can be adopted smoothly, to enhance collaboration, increase transparency and drive productivity gains.
